QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.028670v1 71/1/169    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roman, D. L. Articles by Neubig, R. R. Search for Related Content PubMed PubMed Citation Articles by Roman, D. L. Articles by Neubig, R. R.

Identification of Small-Molecule Inhibitors of RGS4 Using a High-Throughput Flow Cytometry Protein Interaction Assay

Departments of Pharmacology (D.L.R., J.N.T., R.A.R., R.K.S., J.R.T., R.R.N.) and Internal Medicine (Cardiovascular Medicine) (R.R.N.), and the Center for Chemical Genomics, the University of Michigan Life Sciences Institute (R.R.N.), University of Michigan Medical School, Ann Arbor, Michigan

Regulators of G-protein signaling (RGS) proteins are important components of signal transduction pathways initiated through G-protein-coupled receptors (GPCRs). RGS proteins accelerate the intrinsic GTPase activity of G-protein -subunits (G) and thus shorten the time course and reduce the magnitude of G-protein - and -subunit signaling. Inhibiting RGS action has been proposed as a means to enhance the activity and specificity of GPCR agonist drugs, but pharmacological targeting of protein-protein interactions has typically been difficult. The aim of this project was to identify inhibitors of RGS4. Using a Luminex 96-well plate bead analyzer and a novel flow-cytometric protein interaction assay to assess G-RGS interactions in a high-throughput screen, we identified the first small-molecule inhibitor of an RGS protein. Of 3028 compounds screened, 1, methyl N-[(4-chlorophenyl)sulfonyl]-4-nitrobenzenesulfinimidoate (CCG-4986), inhibited RGS4/G_o binding with 3 to 5 µM potency. It binds to RGS4, inhibits RGS4 stimulation of G_o GTPase activity in vitro, and prevents RGS4 regulation of µ-opioid-inhibited adenylyl cyclase activity in permeabilized cells. Furthermore, CCG-4986 is selective for RGS4 and does not inhibit RGS8. Thus, we demonstrate the feasibility of targeting RGS/G protein-protein interactions with small molecules as a novel means to modulate GPCR-mediated signaling processes.

Address correspondence to: Dr. Richard R. Neubig, University of Michigan Medical School, Department of Pharmacology, 1150 W. Medical Center Drive, 1303 MSRB III, Ann Arbor, MI 41809. E-mail: rneubig{at}umich.edu

This article has been cited by other articles:

				W. Hu, F. Li, S. Mahavadi, and K. S. Murthy Upregulation of RGS4 expression by IL-1{beta} in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3{beta} pathway Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1310 - C1320. [Abstract] [Full Text] [PDF]

				B. L. Goldenstein, B. W. Nelson, K. Xu, E. J. Luger, J. A. Pribula, J. M. Wald, L. A. O'Shea, D. Weinshenker, R. A. Charbeneau, X. Huang, et al. Regulator of G Protein Signaling Protein Suppression of G{alpha}o Protein-Mediated {alpha}2A Adrenergic Receptor Inhibition of Mouse Hippocampal CA3 Epileptiform Activity Mol. Pharmacol., May 1, 2009; 75(5): 1222 - 1230. [Abstract] [Full Text] [PDF]

				C. R. Evelyn, T. Ferng, R. J. Rojas, M. J. Larsen, J. Sondek, and R. R. Neubig High-Throughput Screening for Small-Molecule Inhibitors of LARG-Stimulated RhoA Nucleotide Binding via a Novel Fluorescence Polarization Assay J Biomol Screen, February 1, 2009; 14(2): 161 - 172. [Abstract] [PDF]

				A. Shankaranarayanan, D. M. Thal, V. M. Tesmer, D. L. Roman, R. R. Neubig, T. Kozasa, and J. J. G. Tesmer Assembly of High Order G{alpha}q-Effector Complexes with RGS Proteins J. Biol. Chem., December 12, 2008; 283(50): 34923 - 34934. [Abstract] [Full Text] [PDF]

				I. Iankova, C. Chavey, C. Clape, C. Colomer, N. C. Guerineau, N. Grillet, J.-F. Brunet, J.-S. Annicotte, and L. Fajas Regulator of G Protein Signaling-4 Controls Fatty Acid and Glucose Homeostasis Endocrinology, November 1, 2008; 149(11): 5706 - 5712. [Abstract] [Full Text] [PDF]

				S. M. Noorwez, D. A. Ostrov, J. H. McDowell, M. P. Krebs, and S. Kaushal A High-Throughput Screening Method for Small-Molecule Pharmacologic Chaperones of Misfolded Rhodopsin Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3224 - 3230. [Abstract] [Full Text] [PDF]

				M. J. Clark, J. J. Linderman, and J. R. Traynor Endogenous Regulators of G Protein Signaling Differentially Modulate Full and Partial {micro}-Opioid Agonists at Adenylyl Cyclase as Predicted by a Collision Coupling Model Mol. Pharmacol., May 1, 2008; 73(5): 1538 - 1548. [Abstract] [Full Text] [PDF]

				S. Lutz, A. Shankaranarayanan, C. Coco, M. Ridilla, M. R. Nance, C. Vettel, D. Baltus, C. R. Evelyn, R. R. Neubig, T. Wieland, et al. Structure of G{alpha}q-p63RhoGEF-RhoA Complex Reveals a Pathway for the Activation of RhoA by GPCRs Science, December 21, 2007; 318(5858): 1923 - 1927. [Abstract] [Full Text] [PDF]

				S. Gu, J. He, W.-T. Ho, S. Ramineni, D. M. Thal, R. Natesh, J. J. G. Tesmer, J. R. Hepler, and S. P. Heximer Unique Hydrophobic Extension of the RGS2 Amphipathic Helix Domain Imparts Increased Plasma Membrane Binding and Function Relative to Other RGS R4/B Subfamily Members J. Biol. Chem., November 9, 2007; 282(45): 33064 - 33075. [Abstract] [Full Text] [PDF]

				J. Bodenstein, R. K. Sunahara, and R. R. Neubig N-Terminal Residues Control Proteasomal Degradation of RGS2, RGS4, and RGS5 in Human Embryonic Kidney 293 Cells Mol. Pharmacol., April 1, 2007; 71(4): 1040 - 1050. [Abstract] [Full Text] [PDF]